Cargando…

Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer

Chimeric antigen receptor (CAR) T cells represent a novel targeted approach to overcome both quantitative and qualitative shortfalls of the host immune system relating to the detection and subsequent destruction of tumors. The identification of antigens expressed specifically on the surface of tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owens, Gemma L., Sheard, Victoria E., Kalaitsidou, Milena, Blount, Daniel, Lad, Yatish, Cheadle, Eleanor J., Edmondson, Richard J., Kooner, Gurdeep, Gilham, David E., Harrop, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Basic Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895166/ https://www.ncbi.nlm.nih.gov/pubmed/29239915 http://dx.doi.org/10.1097/CJI.0000000000000203

Ejemplares similares

CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity
por: Kueberuwa, Gray, et al.
Publicado: (2017)

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells
por: Owens, Gemma L., et al.
Publicado: (2018)

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
por: Kueberuwa, Gray, et al.
Publicado: (2018)

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors
por: Gérard, Catherine, et al.
Publicado: (2015)

Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers
por: Wang, Xueyin, et al.
Publicado: (2021)

Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation
por: Koruth, Jacob S, et al.
Publicado: (2020)

Efficacy of (S)-lacosamide in preclinical models of cephalic pain
por: Moutal, Aubin, et al.
Publicado: (2016)

Translating genetic and preclinical findings into autism therapies
por: Chahrour, Maria, et al.
Publicado: (2017)

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
por: Schmidts, Andrea, et al.
Publicado: (2022)

89723 CD105-targeted CAR T cells for the treatment of acute myeloid leukemia
por: Lontos, Konstantinos, et al.
Publicado: (2021)

Transmission Electron Microscopy of the Preclinical Phase of Experimental Phytophotodermatitis
por: de Almeida, Hiram Larangeira, et al.
Publicado: (2008)

Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer
por: Ao, Xiang, et al.
Publicado: (2019)

CD3ζ-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy
por: Bridgeman, J S, et al.
Publicado: (2014)

Modular Chimeric Antigen Receptor Systems for Universal CAR T Cell Retargeting
por: Sutherland, Ashley R., et al.
Publicado: (2020)

Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity
por: Cazaux, Marine, et al.
Publicado: (2019)

Cure of Disseminated Human Lymphoma with [(225)Ac]Ac-Ofatumumab in a Preclinical Model
por: Longtine, Mark S., et al.
Publicado: (2023)

Development of Engineered CAR T Cells Targeting Tumor-Associated Glycoforms of MUC1 for the Treatment of Intrahepatic Cholangiocarcinoma
por: Mao, Li, et al.
Publicado: (2023)

Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma
por: Brahm, Cyrillo G, et al.
Publicado: (2020)

Preclinical Evaluation of CAR T Cell Function: In Vitro and In Vivo Models
por: Si, Xiaohui, et al.
Publicado: (2022)

TCR-independent Activation in Presence of a Src-family Kinase Inhibitor Improves CAR-T Cell Product Attributes
por: Lamture, Gauri, et al.
Publicado: (2022)

Cure of Disseminated Human Lymphoma with [(177)Lu]Lu-Ofatumumab in a Preclinical Model
por: Shim, Kyuhwan, et al.
Publicado: (2023)

Preclinical Efficacy of BCMA-Directed CAR T Cells Incorporating a Novel D Domain Antigen Recognition Domain
por: Buonato, Janine M., et al.
Publicado: (2022)

Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
por: Mhaidly, Rana, et al.
Publicado: (2020)

Preclinical Assessment of the Proliferation Capacity of Gingival and Periodontal Ligament Stem Cells from Diabetic Patients
por: Assem, Mostafa, et al.
Publicado: (2018)

In vitro and in vivo assessment of biocompatibility of AZ31 alloy as biliary stents: a preclinical approach
por: Song, Yong, et al.
Publicado: (2020)

Growth modulation of angular deformities with a novel constant force implant concept-preclinical results
por: Buschbaum, Jan, et al.
Publicado: (2021)

Virological and Preclinical Characterization of a Dendritic Cell Targeting, Integration-deficient Lentiviral Vector for Cancer Immunotherapy
por: Odegard, Jared M., et al.
Publicado: (2015)

Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells
por: Salman, Huda, et al.
Publicado: (2019)

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
por: Greven, D E A, et al.
Publicado: (2015)

GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies
por: Zhang, Xi, et al.
Publicado: (2023)

Suppression of CHRN endocytosis by carbonic anhydrase CAR3 in the pathogenesis of myasthenia gravis
por: Du, Ailian, et al.
Publicado: (2017)

Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts
por: Adolph, Timon E, et al.
Publicado: (2022)

Effects of stem cell–derived exosome therapy on erectile dysfunction: a systematic review and meta-analysis of preclinical studies
por: Zhu, Yunpei, et al.
Publicado: (2023)

Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies
por: Odunsi, Adekunle, et al.
Publicado: (2020)

CAR-tropic extracellular vesicles carry tumor-associated antigens and modulate CAR T cell functionality
por: Ukrainskaya, V. M., et al.
Publicado: (2023)

The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma
por: Horbinski, Craig, et al.
Publicado: (2021)

Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells
por: Shrestha, Bishwas, et al.
Publicado: (2020)

Novel green synthesis of silver nanoparticles mediated by Curcumae kwangsiensis for anti-lung cancer activities: a preclinical trial study
por: Liu, Zhihong, et al.
Publicado: (2021)

Preclinical and clinical studies of CAR-NK-cell therapies for malignancies
por: Li, Hongwen, et al.
Publicado: (2022)

Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells
por: Zhao, Songbo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hbcckp0beas4pu1ucp1aqbiare